Assembly Biosciences (ASMB) Non Operating Income (2011 - 2026)

Assembly Biosciences' Non Operating Income history runs 16 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• In Q1 2026, Non Operating Income rose 104.01% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $7.2 million (up 42.03% YoY), while the FY2025 annual figure was $6.0 million, up 7.59% from the prior year.
• Non Operating Income was $2.3 million for Q1 2026 at Assembly Biosciences, roughly flat from $2.3 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $2.3 million in Q4 2025 to a low of $71000.0 in Q1 2022.
• Historically, Non Operating Income has averaged $1.1 million across 5 years, with a median of $1.1 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Non Operating Income surged 757.75% in 2023, then slumped 38.57% in 2025.
• A 5-year view of Non Operating Income shows it stood at $583000.0 in 2022, then soared by 178.22% to $1.6 million in 2023, then plunged by 30.89% to $1.1 million in 2024, then jumped by 104.37% to $2.3 million in 2025, then changed by 0.0% to $2.3 million in 2026.
• The last three Non Operating Income figures came in at $2.3 million (Q1 2026), $2.3 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.